Jpmorgan Chase & Co »

Crescent Biopharma shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $202 17 11.88

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Meta Platforms Common (META)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Broadcom Common (AVGO)
Alphabet Common (GOOG)
Tesla Common (TSLA)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Vanguard S&p 500 Etf Fund (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Oracle Corp Common (ORCL)
Abbvie Common (ABBV)

View all positions for Jpmorgan Chase & Co

Top funds holding Crescent Biopharma

Fairmount Funds Management
VR Adviser
Fcpm Iii Services B.v.
Vestal Point Capital
FMR
BVF
Opaleye Management
Tang Capital Management
ADAR1 Capital Management
Logos Global Management
Vanguard Group
Perceptive Advisors
Deep Track Capital
Boxer Capital Management
Rtw Investments

View all funds holding Crescent Biopharma